Patten & Patten Inc Abbott Laboratories Transaction History

Patten & Patten Inc

$1.43 Billion
Q3 2024

A detailed history of Patten & Patten Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Patten & Patten Inc holds 164,210 shares of ABT stock, worth $19 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

164,210

Previous 166,007 1.08%

Holding current value

$19 Million

Previous $17.2 Million 8.53%

% of portfolio

1.31%

Previous 1.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$100.07 - $118.13 $179,825 - $212,279	-1,797 Reduced 1.08%	164,210 $18.7 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $268,344 - $299,540	-2,664 Reduced 1.58%	166,007 $17.2 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $163,513 - $180,593	1,493 Added 0.89%	168,671 $19.2 Million
Q4 2023 Jan 23, 2024	SELL	$90.19 - $110.4 $1.58 Million - $1.94 Million	-17,553 Reduced 9.5%	167,178 $18.4 Million
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $258,026 - $309,588	-2,701 Reduced 1.44%	184,731 $17.9 Million
Q2 2023 Jul 14, 2023	BUY	$100.78 - $112.29 $57,142 - $63,668	567 Added 0.3%	187,432 $20.4 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $64,218 - $75,588	-663 Reduced 0.35%	186,865 $18.9 Million
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $210,177 - $246,570	-2,211 Reduced 1.17%	187,528 $20.6 Million
Q3 2022 Oct 19, 2022	SELL	$96.76 - $112.03 $241,125 - $279,178	-2,492 Reduced 1.3%	189,739 $18.4 Million
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $579,349 - $700,248	-5,676 Reduced 2.87%	192,231 $20.9 Million
Q1 2022 Apr 25, 2022	BUY	$114.02 - $139.04 $100,109 - $122,077	878 Added 0.45%	197,907 $23.4 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $53,721 - $65,778	465 Added 0.24%	197,029 $27.7 Million
Q3 2021 Oct 22, 2021	SELL	$116.66 - $129.06 $57,630 - $63,755	-494 Reduced 0.25%	196,564 $23.2 Million
Q2 2021 Jul 13, 2021	SELL	$105.79 - $124.53 $688,587 - $810,565	-6,509 Reduced 3.2%	197,058 $22.8 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $68,569 - $80,784	-630 Reduced 0.31%	203,567 $24.4 Million
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $1,995 - $2,173	19 Added 0.01%	204,197 $22.4 Million
Q3 2020 Oct 08, 2020	SELL	$91.64 - $111.29 $169,259 - $205,552	-1,847 Reduced 0.9%	204,178 $22.2 Million
Q2 2020 Jul 21, 2020	SELL	$76.57 - $98.0 $176,570 - $225,988	-2,306 Reduced 1.11%	206,025 $18.8 Million
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $233,376 - $341,259	-3,715 Reduced 1.75%	208,331 $16.4 Million
Q4 2019 Jan 13, 2020	BUY	$78.51 - $87.4 $46,320 - $51,566	590 Added 0.28%	212,046 $18.4 Million
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $131,516 - $142,605	-1,607 Reduced 0.75%	211,456 $17.7 Million
Q2 2019 Jul 11, 2019	SELL	$72.88 - $85.0 $203,699 - $237,575	-2,795 Reduced 1.29%	213,063 $17.9 Million
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $17,283 - $20,895	-261 Reduced 0.12%	215,858 $17.3 Million
Q4 2018 Jan 17, 2019	BUY	$65.56 - $74.27 $8.4 Million - $9.51 Million	128,055 Added 145.41%	216,119 $15.6 Million
Q3 2018 Oct 17, 2018	BUY	$60.81 - $73.36 $1.65 Million - $2 Million	27,215 Added 44.73%	88,064 $6.46 Million
Q2 2018 Jul 18, 2018	BUY	$57.57 - $63.54 $601,894 - $664,310	10,455 Added 20.75%	60,849 $3.71 Million
Q1 2018 Apr 20, 2018	BUY	$56.27 - $63.62 $1.01 Million - $1.15 Million	18,005 Added 55.59%	50,394 $3.02 Million
Q4 2017 Jan 22, 2018	BUY	$53.68 - $57.47 $793,122 - $849,119	14,775 Added 83.88%	32,389 $1.85 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $846,528 - $944,814	17,614	17,614 $940,000

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.

Account

Patten & Patten Inc Abbott Laboratories Transaction History